Target Name: LOC107986141
NCBI ID: G107986141
Other Name(s): LOC107986141 variant X2 | Uncharacterized LOC107986141, transcript variant X2 | uncharacterized LOC107986141

LOC107986141: A Protein with Unique Structure and Potential Drug Target

LOC107986141 (LOC107986141 variant X2) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in high abundance in response to increased levels of thermal stress.

LOC107986141 variant X2 is unique because it has a unique structure compared to other HSPs. Unlike other HSPs, LOC107986141 has a C-terminal glycosylation, which is a covalent modification that adds a glucose molecule to a specific amino acid residue. This modification is important for the protein's stability and functions as it allows the protein to interact with other molecules in the body.

In addition to its unique structure, LOC107986141 variant X2 has also been shown to play a role in several cellular processes. For example, it has been shown to be involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. Additionally, LOC107986141 has been shown to be involved in the regulation of cell cycle progression, which is the process by which cells grow, divide, and replicate their genetic material.

Given its unique structure and its involvement in several cellular processes, LOC107986141 variant X2 is a promising drug target. Researchers are currently working to develop compounds that can inhibit the activity of LOC107986141 variant X2 and use it as a drug for various diseases, such as cancer, neurodegenerative diseases, and autoimmune diseases.

One approach that researchers are using to develop compounds that can inhibit the activity of LOC107986141 variant X2 is to use a technique called high-throughput screening. This involves using a large library of compounds to identify those that can inhibit the activity of the protein. By using this approach, researchers have been able to identify several compounds that are currently being tested in clinical trials as potential drugs for various diseases.

Another approach that researchers are using to develop compounds that can inhibit the activity of LOC107986141 variant X2 is to use structural bioinformatics. This involves using computer-based tools to predict the structure and activity of new compounds based on their chemical formula. By using this approach, researchers have been able to identify several compounds that have the potential to inhibit the activity of LOC107986141 variant X2.

While the development of compounds that can inhibit the activity of LOC107986141 variant X2 is an promising approach to developing new drugs, there are also concerns about the potential side effects of these compounds. For example, since LOC107986141 variant X2 is involved in several cellular processes, inhibiting its activity could have unintended consequences on the body's normal functions.

To address these concerns, researchers are working to develop compounds that are safe and have minimal side effects. This is an important step in the development of new drugs, as it allows researchers to test the safety and effectiveness of these compounds on human volunteers.

Overall, LOC107986141 variant X2 is a protein that is expressed in various tissues of the body and plays a role in several cellular processes. Its unique structure and its involvement in cellular processes make it a promising drug target. While the development of compounds that can inhibit its activity is an promising approach to developing new drugs, it is important to carefully consider the potential side effects of these compounds and work to develop safe and effective drugs.

Protein Name: Uncharacterized LOC107986141

More Common Targets

LOC107986142 | LOC107986146 | LOC107986148 | LOC107986166 | LOC107986178 | LOC107986186 | LOC107986195 | LOC107986203 | LOC107986205 | LOC107986215 | LOC107986223 | LOC107986229 | LOC107986257 | LOC107986272 | LOC107986286 | LOC107986291 | LOC107986297 | LOC107986298 | LOC107986300 | LOC107986362 | LOC107986368 | LOC107986385 | LOC107986400 | LOC107986420 | LOC107986429 | LOC107986440 | LOC107986451 | LOC107986452 | LOC107986453 | LOC107986454 | LOC107986469 | LOC107986517 | LOC107986522 | LOC107986528 | LOC107986537 | LOC107986544 | LOC107986545 | LOC107986561 | LOC107986589 | LOC107986594 | LOC107986595 | LOC107986597 | LOC107986598 | LOC107986606 | LOC107986613 | LOC107986622 | LOC107986623 | LOC107986626 | LOC107986636 | LOC107986649 | LOC107986666 | LOC107986764 | LOC107986766 | LOC107986770 | LOC107986771 | LOC107986772 | LOC107986774 | LOC107986776 | LOC107986777 | LOC107986781 | LOC107986787 | LOC107986800 | LOC107986816 | LOC107986820 | LOC107986836 | LOC107986844 | LOC107986873 | LOC107986892 | LOC107986894 | LOC107986901 | LOC107986903 | LOC107986927 | LOC107986930 | LOC107986952 | LOC107986961 | LOC107986983 | LOC107986996 | LOC107987026 | LOC107987045 | LOC107987049 | LOC107987053 | LOC107987057 | LOC107987064 | LOC107987087 | LOC107987099 | LOC107987121 | LOC107987164 | LOC107987178 | LOC107987211 | LOC107987243 | LOC107987249 | LOC107987251 | LOC107987282 | LOC107987285 | LOC107987299 | LOC107987301 | LOC107987304 | LOC107987407 | LOC107987412 | LOC107987429